Change Page Size of List
Page Size  
No record to display
Summary:

The confidentiality of information under (c) shall be maintained. Information under (c) shall only be used for the following purposes: to provide immunization services to the patient or client, to provide third-party payer immunization payments, to compile and distribute statistical information (without identifying information), and as physicians are authorized by Division 1, Part 2.6 of the Civil Code.

Summary:

A clinical laboratory shall report all CD4+ T-Cell test results that are possibly related to an HIV infection to the local health officer within seven days of the completion of the CD4+ T-Cell test. If provided by the ordering health care provider, the lab report shall include: the patient's name, date of birth, and gender. The local health officer shall inspect each CD4+ T-Cell test report to determine if the test is related to a case of HIV infection. If the test result is related to a case of HIV infection, the local health officer shall report the case of HIV infection or AIDS to the State Department of Public Health within 45 days of receipt of the laboratory report. If the clinical laboratory CD4+ T-Cell test result is not related to a case of HIV infection, the local health officer shall destroy the laboratory CD4+ T-Cell test report. CD4+ T-Cell test reports shall not be disclosed, discoverable, or compelled to be produced in any civil, criminal, administrative, or other proceeding; and shall be consi

Summary:

(c) Except as provided in paragraphs (1) to (3), inclusive, any disclosure authorized by subdivision (a) or (b) shall include only the information necessary for the purpose of that disclosure and shall be made only upon agreement that the information will be kept confidential and will not be further disclosed without written authorization, as described in subdivision (a). (1) Notwithstanding any other provision of law, the following disclosures shall be authorized for the purpose of enhancing completeness of HIV/AIDS, tuberculosis, and sexually transmitted disease coinfection reporting to the federal Centers for Disease Control and Prevention (CDC): (A) The local public health agency HIV surveillance staff may further disclose the information to the health care provider who provides HIV care to the HIV-positive person who is the subject of the record for the purpose of assisting in compliance with subdivision (a) of Section 121022. (B) Local public health agency tuberculosis control staff may further disclose the information to state public health agency tuberculosis control staff, who may further disclose the information, without disclosing patient identifying information, to the CDC, to the extent the information is requested by the CDC and permitted by subdivision (b), for purposes of the investigation, control, or surveillance of HIV and tuberculosis coinfections. (C) Local public health agency sexually transmitted disease control staff may further disclose the information to state public health agency sexually transmitted disease control staff, who may further disclose the information, without disclosing patient identifying information, to the CDC, to the extent it is requested by the CDC, and permitted by subdivision (b), for the purposes of the investigation, control, or surveillance of HIV and syphilis, gonorrhea, or chlamydia coinfection. (2) Notwithstanding any other provision of law, the following disclosures shall be authorized for the purpose of facilitating appropriate HIV/AIDS medical care and treatment: (A) State public health agency HIV surveillance staff, AIDS Drug Assistance Program staff, and care services staff may further disclose the information to local public health agency staff, who may further disclose the information to the HIV-positive person who is the subject of the record, or the health care provider who provides his or her HIV care, for the purpose of proactively offering and coordinating care and treatment services to him or her. (B) AIDS Drug Assistance Program staff and care services staff in the State Department of Public Health may further disclose the information directly to the HIV-positive person who is the subject of the record or the health care provider who provides his or her HIV care, for the purpose of proactively offering and coordinating care and treatment services to him or her. (C) Local public health agency staff may further disclose acquired or developed information to the HIV-positive person who is the subject of the record or the health care provider who provides his or her HIV care for the purpose of proactively offering and coordinating care and treatment services to him or her. (3) Notwithstanding any other provision of law, for the purpose of facilitating appropriate medical care and treatment of persons coinfected with HIV, tuberculosis, and syphilis, gonorrhea, or chlamydia, local public health agency sexually transmitted disease control and tuberculosis control staff may further disclose the information to state or local public health agency sexually transmitted disease control and tuberculosis control staff, the HIV-positive person who is the subject of the record, or the health care provider who provides his or her HIV, tuberculosis, and sexually transmitted disease care. (4) For the purposes of paragraphs (2) and (3), “staff” shall not include nongovernmental entities, but shall include state and local contracted employees who work within state and local public health departments. Exceptions: disclosures authorized (1) for the purpose of enhancing completeness of HIV/AIDS, tuberculosis, and sexually transmitted disease coinfection reporting to the federal Centers for Disease Control and Prevention (CDC); (2) to facilitate appropriate HIV/AIDS medical care and treatment; (3) to facilitate appropriate medical care and treatment of persons coinfected with HIV, tuberculosis, and any STD(s), the local public health agency STD and tuberculosis control staff may further disclose the information to (i) the state or local public health agency staff, (ii) the HIV-positive person who is the subject of the record, or (iii) the health care provider who provides his or her HIV, tuberculosis, and sexually transmitted disease care.

Summary:

Safe-surrender site personnel must ensure a medical screening exam and any necessary medical care is provided to child and notify child protective services within 48 hours of obtaining physical custody of the child, and provide any medical information obtained pertinent to the child's health. No consent is required to provide the child with medical care. Any personal identifying information that pertains to a parent or individual who surrenders a child is confidential and shall be exempt from disclosure by child protective services under the Public Records Act but the parent or relative may be contacted in the event the child suffers a life-threatening event that could benefit from a relative participating in the treatment.

Summary:

Every health care service plan shall provide an external, independent review process to examine the plan's coverage decisions regarding experimental or investigational therapies for individual enrollees with a life-threatening or seriously debilitating condition. The enrollee's physician must certify that the enrollee has a condition for which standard therapies are not effective or medically appropriate; the physician certification shall include a statement of the evidence relied upon by the physician in certifying his or her recommendation.

Summary:

Claimants may obtain, upon request, copies of claim-related documents. However, certain documents, including documents that contain medically privileged information, are excluded from the documents an insurer is required to provide to a claimant.

Summary:

Any person who willfully discloses genetic information that identifies the individual to a third party is liable for civil fines and a misdemeanor. Negligent disclosure is also subject to a civil fine payable to the test subject.

Summary:

Disability insurers may establish reasonable requirements for the participating obstetrician and gynecologist or the family practice physician and surgeon, to communicate with the policyholder's primary care physician regarding the policyholder's condition, treatment, and any need for followup care.

Summary:

Upon receipt of information and documents related to a case, the medical professional reviewer or reviewers selected to conduct the review by the independent medical review organization shall promptly review all pertinent medical records of the insured, provider reports, as well as any other information submitted to the organization as authorized by the department or requested from any of the parties to the dispute by the reviewers. If reviewers request information from any of the parties, a copy of the request and the response shall be provided to all of the parties.

Summary:

A Medicare Select issuer shall comply with reasonable requests for data made by state or federal agencies, including the United States Department of Health and Human Services for the purpose of evaluating the Medicare Select program.

Now viewing : Page 1 of 95 first     previous     next     last